These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 30867205)

  • 1. Association between full monitoring of biomedical and lifestyle target indicators and HbA
    van Bruggen S; Rauh SP; Kasteleyn MJ; Bonten TN; Chavannes NH; Numans ME
    BMJ Open; 2019 Mar; 9(3):e027208. PubMed ID: 30867205
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Socioeconomic status is not associated with the delivery of care in people with diabetes but does modify HbA1c levels: An observational cohort study (Elzha-cohort 1).
    van Bruggen S; Kasteleyn MJ; Bonten TN; Chavannes NH; Numans ME; Rauh SP
    Int J Clin Pract; 2021 May; 75(5):e13962. PubMed ID: 33368962
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between GP participation in a primary care group and monitoring of biomedical and lifestyle target indicators in people with type 2 diabetes: a cohort study (ELZHA cohort-1).
    van Bruggen S; Rauh SP; Bonten TN; Chavannes NH; Numans ME; Kasteleyn MJ
    BMJ Open; 2020 Apr; 10(4):e033085. PubMed ID: 32345697
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blood glucose self-monitoring in type 2 diabetes: a randomised controlled trial.
    Farmer AJ; Wade AN; French DP; Simon J; Yudkin P; Gray A; Craven A; Goyder L; Holman RR; Mant D; Kinmonth AL; Neil HA;
    Health Technol Assess; 2009 Feb; 13(15):iii-iv, ix-xi, 1-50. PubMed ID: 19254484
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of professional-mode flash glucose monitoring, at 3-month intervals, in adults with type 2 diabetes in general practice (GP-OSMOTIC): a pragmatic, open-label, 12-month, randomised controlled trial.
    Furler J; O'Neal D; Speight J; Blackberry I; Manski-Nankervis JA; Thuraisingam S; de La Rue K; Ginnivan L; Doyle R; Holmes-Truscott E; Khunti K; Dalziel K; Chiang J; Audehm R; Kennedy M; Clark M; Jenkins A; Lake AJ; Januszewski AS; Catchpool M; Liew D; Clarke P; Best J
    Lancet Diabetes Endocrinol; 2020 Jan; 8(1):17-26. PubMed ID: 31862147
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of supported telemetric monitoring in people with type 2 diabetes: study protocol for a randomised controlled trial.
    Wild S; Hanley J; Lewis S; McKnight J; McCloughan L; Padfield P; Paterson M; Pinnock H; McKinstry B
    Trials; 2013 Jul; 14():198. PubMed ID: 23829417
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of an mHealth-enabled hierarchical diabetes management intervention in primary care in China (ROADMAP): A cluster randomized trial.
    Jia W; Zhang P; Zhu D; Duolikun N; Li H; Bao Y; Li X;
    PLoS Med; 2021 Sep; 18(9):e1003754. PubMed ID: 34547030
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Flash Glucose Monitoring Improves Glucose Control in People with Type 2 Diabetes Mellitus Receiving Anti-diabetic Drug Medication.
    Chen M; Li H; Shen Y; Liu B; Yan R; Sun X; Ye L; Lee KO; Ma J; Su X
    Exp Clin Endocrinol Diabetes; 2021 Dec; 129(12):857-863. PubMed ID: 32858752
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Continuous Glucose Monitoring With Low-Carbohydrate Nutritional Coaching to Improve Type 2 Diabetes Control: Randomized Quality Improvement Program.
    Griauzde DH; Ling G; Wray D; DeJonckheere M; Mizokami Stout K; Saslow LR; Fenske J; Serlin D; Stonebraker S; Nisha T; Barry C; Pop-Busui R; Sen A; Richardson CR
    J Med Internet Res; 2022 Feb; 24(2):e31184. PubMed ID: 35107429
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Supported Telemonitoring and Glycemic Control in People with Type 2 Diabetes: The Telescot Diabetes Pragmatic Multicenter Randomized Controlled Trial.
    Wild SH; Hanley J; Lewis SC; McKnight JA; McCloughan LB; Padfield PL; Parker RA; Paterson M; Pinnock H; Sheikh A; McKinstry B
    PLoS Med; 2016 Jul; 13(7):e1002098. PubMed ID: 27458809
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ROSSO-in-praxi-international: long-term effects of self-monitoring of blood glucose on glucometabolic control in patients with type 2 diabetes mellitus not treated with insulin.
    Kempf K; Tankova T; Martin S
    Diabetes Technol Ther; 2013 Jan; 15(1):89-96. PubMed ID: 23194054
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BetaMe: impact of a comprehensive digital health programme on HbA1c and weight at 12 months for people with diabetes and pre-diabetes: study protocol for a randomised controlled trial.
    Sarfati D; McLeod M; Stanley J; Signal V; Stairmand J; Krebs J; Dowell A; Leung W; Davies C; Grainger R
    Trials; 2018 Mar; 19(1):161. PubMed ID: 29506562
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Redesigning ambulatory care management for uncontrolled type 2 diabetes: a prospective cohort study of the impact of a Boot Camp model on outcomes.
    Magee MF; Baker KM; Fernandez SJ; Huang CC; Mete M; Montero AR; Nassar CM; Sack PA; Smith K; Youssef GA; Evans SR
    BMJ Open Diabetes Res Care; 2019; 7(1):e000731. PubMed ID: 31798894
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Short-term intensive insulin therapy could be the preferred option for new onset Type 2 diabetes mellitus patients with HbA1c > 9.
    Weng J
    J Diabetes; 2017 Oct; 9(10):890-893. PubMed ID: 28661564
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Health Coaching Reduces HbA1c in Type 2 Diabetic Patients From a Lower-Socioeconomic Status Community: A Randomized Controlled Trial.
    Wayne N; Perez DF; Kaplan DM; Ritvo P
    J Med Internet Res; 2015 Oct; 17(10):e224. PubMed ID: 26441467
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An exploratory trial of basal and prandial insulin initiation and titration for type 2 diabetes in primary care with adjunct retrospective continuous glucose monitoring: INITIATION study.
    Blackberry ID; Furler JS; Ginnivan LE; Manski-Nankervis JA; Jenkins A; Cohen N; Best JD; Young D; Liew D; Ward G; O'Neal DN
    Diabetes Res Clin Pract; 2014 Nov; 106(2):247-55. PubMed ID: 25271117
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in HbA1c level over a 12-week follow-up in patients with type 2 diabetes following a medication change.
    Hirst JA; Stevens RJ; Farmer AJ
    PLoS One; 2014; 9(3):e92458. PubMed ID: 24667212
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Self-monitoring of Blood Glucose in Non-Insulin Treated Type 2 Diabetes (The SMBG Study): study protocol for a randomised controlled trial.
    Parsons S; Luzio S; Bain S; Harvey J; McKenna J; Khan A; Rice S; Watkins A; Owens DR
    BMC Endocr Disord; 2017 Jan; 17(1):4. PubMed ID: 28143495
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Are general practitioners characteristics associated with the quality of type 2 diabetes care in general practice? Results from the Norwegian ROSA4 study from 2014.
    Tran AT; Bakke Å; Berg TJ; Gjelsvik B; Mdala I; Nøkleby K; Shakil Rai A; Cooper JG; Claudi T; Løvaas K; Thue G; Sandberg S; Jenum AK
    Scand J Prim Health Care; 2018 Jun; 36(2):170-179. PubMed ID: 29717939
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improving type 2 diabetes mellitus glycaemic outcomes is possible without spending more on medication: Lessons from the UK National Diabetes Audit.
    Heald AH; Livingston M; Malipatil N; Becher M; Craig J; Stedman M; Fryer AA
    Diabetes Obes Metab; 2018 Jan; 20(1):185-194. PubMed ID: 28730750
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.